June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
ASSESSING THE PREVALENCE OF ABNORMAL TEAR TESTING IN CATARACT SURGERY PATIENTS USING TWO POINT-OF-CARE DIAGNOSTIC TESTS
Author Affiliations & Notes
  • Owen J Drinkwater
    Weill Cornell Medicine, New York , New York, United States
  • Ashley R Brissette
    Weill Cornell Medicine, New York , New York, United States
  • Christopher E Starr
    Weill Cornell Medicine, New York , New York, United States
  • Footnotes
    Commercial Relationships   Owen Drinkwater, None; Ashley Brissette, None; Christopher Starr, RPS Diagnostics Inc. (C), TearLab Inc. (C)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 791. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Owen J Drinkwater, Ashley R Brissette, Christopher E Starr; ASSESSING THE PREVALENCE OF ABNORMAL TEAR TESTING IN CATARACT SURGERY PATIENTS USING TWO POINT-OF-CARE DIAGNOSTIC TESTS. Invest. Ophthalmol. Vis. Sci. 2017;58(8):791.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Ocular surface disease (OSD) can significantly impact pre-operative measurements for cataract surgery. The purpose of this study is to assess the prevalence of abnormal tear testing in pre-operative cataract surgery patients (pts) using two common point-of-care (POC) diagnostic tests and to assess the correlation between patient symptoms and objective test results.

Methods : A prospective observational study of 34 consecutive pre-operative cataract surgery pts was conducted. Pts with visually significant cataract were included for study at their pre-operative appointment. They were administered 2 questionnaires: the Ocular Surface Disease Index (OSDI) and the Symptom Assessment in Dry Eye (SANDE) questionnaire. All pts then underwent tear osmolarity (osm) testing (TearLabTM) and matrix metalloproteinase-9 (MMP-9) testing (InflammaDryTM) regardless of symptomatology and before the instillation of any drops or other testing. Primary outcome measures included tear film osm, tear MMP-9 level, and questionnaire scores.

Results : Average age was 70.1 ± 7.7 years, and 59% of pts were female. At least 1 abnormal tear test was present in 76% of pts, while 35% of pts were abnormal for both tear tests. 15% of pts had abnormal tear osm (≥308 mOsm/L or inter-eye difference ≥8 mOsm/L) but were negative for MMP-9. An abnormal MMP-9 with normal osm was found in 26% of pts, and in 24% of pts both tests were normal. OSDI and SANDE symptom scores were well correlated (r=0.56, p<0.001). However, there was no significant association between OSDI scores (severe symptoms >33) and abnormal tear osm (p=0.42) or MMP-9 (p=0.63). SANDE scores (severe symptoms >50) also showed no significant association with osm (p=0.22) or MMP-9 levels (p=0.24). Mean OSDI and SANDE scores were similar between the subgroup of pts with 2 abnormal tear tests (37.48 ± 26.51 and 34.35 ± 31.63) and the subgroup that tested normal for both tear tests (34.75 ± 24.92 and 35.65 ± 30.63).

Conclusions : There is a high prevalence of OSD in pts who present for cataract surgery as measured by POC diagnostic tear tests. Signs and symptoms of OSD are often poorly correlated; this study shows a similarly poor correlation, suggesting symptomatology alone may miss affected pts. POC testing may be more useful in identifying early or asymptomatic OSD in pre-operative cataract surgery pts.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×